C-243

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameC-243
Drug Alias Nameleukocyte infiltration inhibitor (SRI)MCP-1 antagonists (Telik)C-243
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 2 antagonistsC-C motif chemokine 2 inhibitors
TargetsC-C chemokine receptor type 2C-C motif chemokine 2
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAsia
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMabvax Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabvax Therapeutics Holdings IncSri InternationalSanwa Kagaku Kenkyusho Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A